fibtem a10 11 mm extem a10 43 mm (Rotem Industries)
Structured Review

Fibtem A10 11 Mm Extem A10 43 Mm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fibtem a10 11 mm extem a10 43 mm/product/Rotem Industries
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Viscoelastic haemostatic assays in chronic liver disease—Profiling coagulation in the emergency department"
Article Title: Viscoelastic haemostatic assays in chronic liver disease—Profiling coagulation in the emergency department
Journal: Vox Sanguinis
doi: 10.1111/vox.70167
Figure Legend Snippet: (a) Violin plots of rotational thromboelastometry (ROTEM) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and interquartile ranges (IQRs) and red shaded reference ranges. (b) Violin plots of thromboelastogram (TEG) parameters ( n = 397). Blue violins show distributions with individual values (crosses), annotated medians and IQRs and red shaded reference ranges. A10, amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.
Techniques Used: Coagulation, FIBTEM Assay, Lysis
Figure Legend Snippet: (a) Patient‐level combinations of fibrinogen, platelet and coagulation factor deficiencies, and hyperfibrinolysis in rotational thromboelastometry (ROTEM) ( n = 397). (b) Patient‐level combinations of fibrinogen, platelet and coagulation factor deficiencies, and hyperfibrinolysis in thromboelastogram (TEG) ( n = 41). A10, amplitude 10 min after start of clotting time (CT); CFF, clot formation time; CK R, clotting time (R‐time) in citrated kaolin channel of TEG 6s; CRT, clot reaction time; EXTEM, extrinsically activated thromboelastometry; FIBTEM, fibrin‐based thromboelastometry; LY30, lysis 30 min after maximum amplitude; MA, maximum amplitude; ML, maximum lysis.
Techniques Used: Coagulation, FIBTEM Assay, Lysis
Figure Legend Snippet: Concordance of fibrinogen, platelet and coagulation factor deficiencies detected by viscoelastic haemostatic assay (VHA) and conventional coagulation test (CCT) in paired samples ( n = 120). Rotational thromboelastometry (ROTEM) and thromboelastogram (TEG) were combined. Definitions: Fibrinogen—ROTEM: Fibrin‐based thromboelastometry (FIBTEM) amplitude 10 min after start of clotting time (CT) (A10) <11 mm; TEG: citrated functional fibrinogen (CFF) maximum amplitude (MA) <15 mm; CCT: Fibrinogen <1.0 g/L. Platelet—ROTEM: FIBTEM A10 ≥11 mm + extrinsically activated thromboelastometry (EXTEM) A10 <43 mm; TEG: CFF MA ≥15 mm + clot reaction time (CRT) MA <50 mm; CCT: Platelets <50 × 10 9 /L. Coagulation factor—ROTEM: EXTEM CT >80 s; TEG: Clotting time (R‐time) in citrated kaolin channel of TEG 6s (CK R) > 9 min; CCT: international normalized ratio (INR) >1.5.
Techniques Used: Coagulation, FIBTEM Assay, Functional Assay

